Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Melanoma and Pancreatic adenocarcinoma.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 1 | Pancreatic adenocarcinoma |
Age of onset: middle age.
Biomarker and diagnostic research for pancreatic cancer, susceptibility to, 5 has been reported in the published literature.
No clinical trials have been registered for pancreatic cancer, susceptibility to, 5.
127 publications have been identified in PubMed for pancreatic cancer, susceptibility to, 5. Kisho has analyzed 56 by research type. Research spans Review / Meta-Analysis (34%), Epidemiology / Natural History (34%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 19 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
Online Mendelian Inheritance in Man
Disease patterns and progression |
19 |
34% |
Laboratory research | 10 | 18% |
Testing and diagnosis research | 6 | 11% |
Clinical study results | 1 | 2% |
New treatment approaches | 1 | 2% |
Lucas AL (2026). [PMID: 41143761](https://pubmed.ncbi.nlm.nih.gov/41143761/). *Gastroenterology*. [Diagnostic / Biomarker]
Masamune A (2026). [PMID: 41247519](https://pubmed.ncbi.nlm.nih.gov/41247519/). *J Gastroenterol*. [Basic Science / Preclinical]
Zhang T (2026). [PMID: 41206949](https://pubmed.ncbi.nlm.nih.gov/41206949/). *J Natl Cancer Inst*. [Epidemiology / Natural History]
Chen Q (2026). [PMID: 41547783](https://pubmed.ncbi.nlm.nih.gov/41547783/). *Mol Cancer*. [Review / Meta-Analysis]
Lewis D (2025). [PMID: 40277782](https://pubmed.ncbi.nlm.nih.gov/40277782/). *Curr Oncol*. [Review / Meta-Analysis]
Katona BW (2025). [PMID: 39611336](https://pubmed.ncbi.nlm.nih.gov/39611336/). *Cancer*. [Epidemiology / Natural History]
Jiang Y (2025). [PMID: 40544258](https://pubmed.ncbi.nlm.nih.gov/40544258/). *Cell Commun Signal*. [Epidemiology / Natural History]
Cheng C (2025). [PMID: 40269157](https://pubmed.ncbi.nlm.nih.gov/40269157/). *Nature*. [Basic Science / Preclinical]
Liu J (2025). [PMID: 40811672](https://pubmed.ncbi.nlm.nih.gov/40811672/). *J Leukoc Biol*. [Epidemiology / Natural History]
Fernandes CJ (2025). [PMID: 40009039](https://pubmed.ncbi.nlm.nih.gov/40009039/). *Pancreas*. [Diagnostic / Biomarker]